Alpine Immune Sciences, Inc. (ALPN) Social Stream
ALPINE IMMUNE SCIENCES INC (ALPN) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ALPN.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-02-04 | 4 | $22 | $19 | $20.666 | $19.66 | 5.12% |
| 2022-08-15 | 4 | $22 | $17 | $20 | $19.66 | 1.73% |
| 2022-09-13 | 4 | $25 | $17 | $21 | $19.66 | 6.82% |
| 2022-10-24 | 4 | $25 | $14 | $20 | $19.66 | 1.73% |
| 2022-11-15 | 4 | $17 | $8 | $13 | $19.66 | -33.88% |
| 2022-11-21 | 5 | $17 | $8 | $13.75 | $19.66 | -30.06% |
| 2023-03-24 | 6 | $17 | $8 | $14.4 | $19.66 | -26.75% |
| 2023-08-15 | 6 | $17 | $11 | $15 | $19.66 | -23.7% |
| 2023-08-31 | 6 | $19 | $14 | $16.6 | $19.66 | -15.56% |
| 2023-09-11 | 6 | $22 | $16 | $18.2 | $19.66 | -7.43% |
| 2023-10-05 | 7 | $22 | $16 | $18.333 | $19.66 | -6.75% |
| 2023-11-03 | 8 | $22 | $16 | $18.285 | $19.66 | -6.99% |
| 2023-11-14 | 8 | $30 | $17 | $24.428 | $19.66 | 24.25% |
| 2023-11-15 | 8 | $30 | $17 | $24 | $19.66 | 22.08% |
| 2023-12-22 | 8 | $32 | $18 | $26.142 | $19.66 | 32.97% |
The Trend in the Analyst Price Target
Over the past 28 months, ALPN's average price target has gone up $6.14.
ALPN reports an average of 57.97% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-08 | 6 | 17 | 8 | 14.4 | 7.77 | 85.33% |
| 2023-08-15 | 6 | 19 | 14 | 16.6 | 13.50 | 22.96% |
| 2023-08-31 | 6 | 19 | 14 | 16.6 | 12.35 | 34.41% |
| 2023-11-03 | 8 | 30 | 17 | 24.0 | 16.07 | 49.35% |
| 2023-11-15 | 8 | 30 | 17 | 24.0 | 12.63 | 90.02% |
ALPN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.13 | 7 | 1 | 0 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
ALPN's average broker recommendation rating improved by 0.28 over the prior 36 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- ALPINE IMMUNE SCIENCES INC's average analyst price target is higher than 405.14% of all US stocks.
- In terms of how ALPINE IMMUNE SCIENCES INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 449.46% of that group.
- ALPINE IMMUNE SCIENCES INC's number of analysts covering the stock is greater than 1077.27% of stocks in the small market cap category.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ALPINE IMMUNE SCIENCES INC's variance in analysts' estimates is lower than -373.11% of them.
Stocks similar to ALPINE IMMUNE SCIENCES INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are VKTX, COLL, and RDHL.
View All Top Stocks by Price Target
What is the outlook for ALPN? Use POWR Ratings for clearer insight into price direction.